{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:23:26Z","timestamp":1761899006958,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T00:00:00Z","timestamp":1508198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Pathology North PTTF","award":["PN-H 06\/2016"],"award-info":[{"award-number":["PN-H 06\/2016"]}]},{"DOI":"10.13039\/100013026","name":"Hunter Cancer Research Alliance","doi-asserted-by":"crossref","award":["HCRA 03\/2016"],"award-info":[{"award-number":["HCRA 03\/2016"]}],"id":[{"id":"10.13039\/100013026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.cancergen.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T14:02:13Z","timestamp":1504274533000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Detection of complex genomic signatures associated with risk in plasma cell disorders"],"prefix":"10.1016","volume":"218-219","author":[{"given":"Nadine K.","family":"Berry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Dixon-McIver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Rowlings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoop K.","family":"Enjeti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2008","author":"IARC I.A.f.R.o.C.","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","key":"10.1016\/j.cancergen.2017.08.004_bib0010"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0015","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/leu.2009.174","article-title":"International Myeloma Working Group molecular classification of multiple myeloma: spotlight review","volume":"23","author":"Fonseca","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.mayocp.2013.01.019","article-title":"Management of newly diagnosed symptomatic multiple myeloma: updated mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus guidelines","volume":"88","author":"Mikhael","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from international Myeloma Working Group","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"year":"2011","author":"IMWG (International Myeloma Working Group)","series-title":"International Myeloma Working Group Molecular Classification Of Multiple Myeloma","key":"10.1016\/j.cancergen.2017.08.004_bib0030"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0035","article-title":"Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow","author":"Berry","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0040","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1182\/blood-2011-03-344069","article-title":"Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients","volume":"118","author":"Magrangeas","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1755-8166-3-23","article-title":"Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic\/myeloproliferative syndromes","volume":"3","author":"Slovak","year":"2010","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cancergencyto.2010.10.007","article-title":"Implementation of high resolution single nucleotide polymorphism array analysis as a clinical test for patients with hematologic malignancies","volume":"204","author":"Dougherty","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0055","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/humu.22057","article-title":"Genome-wide arrays in routine diagnostics of hematological malignancies","volume":"33","author":"Simons","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0060","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.leukres.2010.02.031","article-title":"Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data","volume":"34","author":"Usvasalo","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0065","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cancergen.2011.09.002","article-title":"Genomic profiling in high hyperdiploid acute myeloid leukemia: a retrospective study of 19 cases","volume":"204","author":"Veigaard","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cancergencyto.2009.11.018","article-title":"Array comparative genomic hybridization analysis of adult acute leukemia patients","volume":"197","author":"Yasar","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cancergencyto.2010.11.002","article-title":"The prognostic significance of cytogenetics and molecular profiling in multiple myeloma","volume":"204","author":"Sawyer","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0080","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1182\/blood-2010-04-279596","article-title":"A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value","volume":"116","author":"Walker","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/leu.2013.247","article-title":"IMWG consensus on risk stratification in multiple myeloma","volume":"28","author":"Chng","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0090","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1101\/gad.229559.113","article-title":"Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements","volume":"27","author":"Zhang","year":"2013","journal-title":"Genes Dev"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0095","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2013.02.023","article-title":"Criteria for inference of chromothripsis in cancer genomes","volume":"152","author":"Korbel","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0100","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/gcc.21981","article-title":"Shattered and stitched chromosomes-chromothripsis and chromoanasynthesis-manifestations of a new chromosome crisis?","volume":"51","author":"Righolt","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2012.01.006","article-title":"Chromothripsis and human disease: piecing together the shattering process","volume":"148","author":"Maher","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0115","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.semcdb.2011.07.010","article-title":"The consequences of structural genomic alterations in humans: genomic disorders, genomic instability and cancer","volume":"22","author":"Colnaghi","year":"2011","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0120","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/ijc.29888","article-title":"Chromothripsis in cancer cells: An update","volume":"138","author":"Rode","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ceb.2016.03.003","article-title":"The genomic characteristics and cellular origin of chromothripsis","volume":"40","author":"Storchov\u00e1","year":"2016","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164370","article-title":"Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes","volume":"11","author":"Ab\u00e1igar","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0135","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3324\/haematol.2011.056176","article-title":"Report from the european myeloma network on interphase FISHin multiple myeloma and related disorders","volume":"97","author":"Ross","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.cancergen.2017.08.004_bib0140","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/leu.2015.254","article-title":"Identification of characteristic and prognostic values of chromosome 1p abnormality by multi-gene fluorescence in situ hybridization in multiple myeloma","volume":"30","author":"Li","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0145","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1182\/blood-2015-03-632075","article-title":"Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma","volume":"125","author":"Sawyer","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0150","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2016-01-631200","article-title":"Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group","volume":"127","author":"Sonneveld","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0155","first-page":"1","article-title":"Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group","author":"Grzasko","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0160","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood-2014-07-587964","article-title":"Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience","volume":"125","author":"Hebraud","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0165","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/leu.2013.225","article-title":"Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients","volume":"28","author":"Hebraud","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0170","doi-asserted-by":"crossref","first-page":"7776","DOI":"10.1158\/1078-0432.CCR-11-1791","article-title":"Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival","volume":"17","author":"Boyd","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0175","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1101\/gr.140301.112","article-title":"Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes","volume":"23","author":"Kim","year":"2013","journal-title":"Genome Res"},{"key":"10.1016\/j.cancergen.2017.08.004_bib0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ceb.2013.02.008","article-title":"Chromothripsis in congenital disorders and cancer: similarities and differences","volume":"25","author":"Kloosterman","year":"2013","journal-title":"Curr Opin Cell Biol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221077621730340X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221077621730340X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:48Z","timestamp":1761896508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221077621730340X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":35,"alternative-id":["S221077621730340X"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2017.08.004","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of complex genomic signatures associated with risk in plasma cell disorders","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}